Clinical trials for Rectal cancer

167 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 2 Colon cancer Rectal cancer #NCT07071844 #2024-520128-27-00

[BETWEEN] Bévacizumab bihebdomadaire + Trifluridine/Tipiracil pour réduire la neutropénie de grade 3-4 chez les patients atteints de mCRC

Adenocarcinoma Metastatic MSI/dMMR 1 2 3 or more Chemotherapy Targeted therapy

Systemic Treatment-Naive

3 recruiting sites

GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie

Phase 2 Colon cancer Rectal cancer #NCT06646445 #2023-509322-22-00

[PREMICES] Pembrolizumab néoadjuvant associé à une stratégie de surveillance active pour le cancer du côlon localisé dMMR/MSI-H

Adenocarcinoma Localized MSI/dMMR None Systemic Treatment-Naive

Immunotherapy

1 recruiting site

GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie

Phase 2 Colon cancer Rectal cancer #NCT04659382

[SIRTCI] Étude de la radiothérapie interne sélective + XELOX, BÉVACIZUMAB et ATÉZOLIZUMAB chez les patients atteints d'un cancer colorectal métastatique à prédominance hépatique

Metastatic MSS/pMMR None Systemic Treatment-Naive

MSI/dMMR

6 recruiting sites

Fédération Francophone de Cancérologie Digestive

Phase 2 Colon cancer Rectal cancer Stomach and esophageal cancer #NCT06245356 #2023-508724-35-00

[TRIFLUOX-DP] Innocuité de la TRIFLURIDINE/TIPIRACIL chez les patients présentant un déficit en dihydropyrimidine déshydrogénase diagnostiqué avec un cancer colorectal ou gastro-œsophagien métastatique

Stomach Oesogastric junction Esophagus Adenocarcinoma Metastatic None Systemic Treatment-Naive

4 recruiting sites

UNICANCER

Phase 2 Lung cancer Colon cancer Rectal cancer Endometrial cancer Head and neck cancer Sarcoma and GIST #NCT07192068 #2025-522169-31-00

[AcSé HER2] Essai clinique évaluant l'activité du zanidatamab dans le traitement des patients atteints de tumeurs solides présentant une altération du gène HER2

NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic HER2 1 2 3 or more

Systemic Treatment-Naive

4 recruiting sites

UNICANCER

Phase 2 Colon cancer Rectal cancer #NCT05489211 #2023-509436-26-00

[TROPION-PanTumor03] Étude du DATO-DXD en monothérapie et en association avec des agents anticancéreux chez des patients atteints de tumeurs solides avancées

Cancer colorectal (CCR) (sous-étude 5)

Locally Advanced Metastatic 1 2 3 or more

Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)

2 recruiting sites

AstraZeneca

Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT03767075 #2024-514238-19-00

[BoB] Essai modulaire multi-panier pour améliorer la médecine personnalisée chez les patients atteints de cancer - Partie A et B

Module 2 bras 2B, Module 3 bras 3A et 3C